Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_36959 | 14 | 0.28 | Mlig455_019348, Mlig455_019567, Mlig455_045238 | Neo: - Age: - |
AC243734.1 | Mlig455_019348 {REF} {Length: 1134} Mlig455_019567 {REF} {Length: 1135} Mlig455_045238 {REF} {Length: 1757} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=170.5]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=109.4]} {Human: ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=244, Expect=1e-73]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=244, Expect=1e-73]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=243, Expect=5e-73]; ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=233, Expect=3e-69]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=244, Expect=1e-73]; ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=235, Expect=2e-70]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=252, Expect=5e-76]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=234, Expect=1e-69]} {Smed: dd_Smed_v6_23922_0_1, dd_Smed_v6_23922_0_1, [Score=242, Expect=2e-72]} {RNA1310_104931} {RNA815_34654} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -1.249 | 0.637 | 0.99983 | 1.00000 | |
RegionR2 | 1.151 | 0.637 | 0.87875 | 1.00000 | |
RegionR3 | -0.891 | 0.637 | 0.99984 | 1.00000 | |
RegionR4 | 0.96 | 0.637 | 0.99983 | 1.00000 | |
RegionR5 | -0.165 | 0.637 | 0.99993 | 1.00000 | |
RegionR6 | 2.546 | 0.637 | 0.26191 | 0.84986 | |
RegionR7 | -1.202 | 0.637 | 0.99983 | 1.00000 | |
RegionR8 | -1.151 | 0.637 | 0.99983 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -0.021 | 0.637 | 0.99993 | 1.00000 | |
RegenerationR2 | 0.653 | 0.637 | 0.74656 | 0.97204 | |
RegenerationR3 | 1.553 | 0.637 | 0.63422 | 0.92216 | |
RegenerationR4 | -1.181 | 0.637 | 0.99983 | 1.00000 | |
RegenerationR5 | -0.707 | 0.637 | 0.99983 | 1.00000 | |
RegenerationR6 | -3.685 | 0.637 | 0.05868 | 0.30399 | |
RegenerationBL | -1.611 | 0.637 | 0.99928 | 1.00000 | |
RegenerationTP | -0.649 | 0.637 | 0.99983 | 1.00000 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_36959 | 14 | 0.28 | Mlig455_019348, Mlig455_019567, Mlig455_045238 | Neo: - Age: - |
AC243734.1 | 2 | - | - | 1.000 | - | - | 1.000 | Mlig455_019348 {REF} {Length: 1134} Mlig455_019567 {REF} {Length: 1135} Mlig455_045238 {REF} {Length: 1757} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=170.5]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=109.4]} {Human: ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=244, Expect=1e-73]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=244, Expect=1e-73]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=243, Expect=5e-73]; ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=233, Expect=3e-69]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=244, Expect=1e-73]; ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=235, Expect=2e-70]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=252, Expect=5e-76]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=234, Expect=1e-69]} {Smed: dd_Smed_v6_23922_0_1, dd_Smed_v6_23922_0_1, [Score=242, Expect=2e-72]} {RNA1310_104931} {RNA815_34654} |
2. | MligTC455_42559 | 17 | 0.36 | Mlig455_064128 | Neo: - Age: - |
1.913 | - | - | 0.993 | - | - | 0.920 | Mlig455_064128 {REF} {Length: 1837} {Pfam: Glycine rich protein [PF12810.9, score=23.2]} {RNA1310_112308} {RNA815_32418} | |
3. | MligTC455_17771 | 78 | 1.62 | Mlig455_001663 | Neo: - Age: - |
1.848 | - | - | 0.967 | - | - | 0.881 | Mlig455_001663 {REF} {Length: 1828} {NoTransDecoderORF} {RNA1310_81916} | |
4. | MligTC455_38487 | 21 | 0.43 | Mlig455_035154 | Neo: - Age: - |
1.841 | - | - | 0.871 | - | - | 0.970 | Mlig455_035154 {REF} {Length: 903} {Pfam: WSC domain [PF01822.21, score=52.5]; PAN domain [PF00024.28, score=30.4]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=47.4, Expect=5e-06]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=50.8, Expect=4e-07]} {RNA1310_44717} {RNA815_43195} | |
5. | MligTC455_40658 | 152 | 3.17 | Mlig455_064614 | Neo: - Age: - |
CLIP2 | 1.702 | - | - | 0.725 | - | - | 0.977 | Mlig455_064614 {REF} {Length: 2460} {Pfam: CAP-Gly domain [PF01302.27, score=60.7]} {Human: ENSG00000106665, CLIP2, CAP-Gly domain containing linker protein 2, [Score=61.6, Expect=2e-09]} {Mouse: ENSMUSG00000063146, Clip2, CAP-GLY domain containing linker protein 2, [Score=62.0, Expect=9e-10]} {Dmel: FBgn0036882, CG9279, [Score=55.1, Expect=9e-08]} {Smed: dd_Smed_v6_12985_0_1, dd_Smed_v6_12985_0_1, [Score=56.2, Expect=2e-08]} {RNA1310_20676} {RNA815_40746} |
6. | MligTC455_15327 | 51 | 1.07 | Mlig455_003799, Mlig455_054316 | Neo: - Age: Down-Up-Down |
CPLX1 | 0.998 | - | - | - | - | - | 0.998 | Mlig455_003799 {REF} {Length: 3120} {Pfam: Synaphin protein [PF05835.14, score=100.6]; PVL ORF-50-like family [PF07768.13, score=19.1]} {Human: ENSG00000168993, CPLX1, complexin 1, [RH, Score=55.8, Expect=9e-10]; ENSG00000145920, CPLX2, complexin 2, [RH, Score=54.3, Expect=1e-09]} {Mouse: ENSMUSG00000033615, Cplx1, complexin 1, [Score=57.0, Expect=2e-10]} {Dmel: FBgn0041605, cpx, complexin, [Score=66.2, Expect=9e-14]} {Celegans: WBGene00022271, cpx-1, Putative complexin-1, [Score=77.8, Expect=2e-18]} {Smed: dd_Smed_v6_9918_0_1, dd_Smed_v6_9918_0_1, [Score=91.7, Expect=6e-24]} {RNA1310_47061} Mlig455_054316 {REF} {Length: 3045} {Pfam: Synaphin protein [PF05835.14, score=100.6]; PVL ORF-50-like family [PF07768.13, score=19.1]} {Human: ENSG00000168993, CPLX1, complexin 1, [RH, Score=55.8, Expect=9e-10]; ENSG00000145920, CPLX2, complexin 2, [RH, Score=54.3, Expect=1e-09]} {Mouse: ENSMUSG00000033615, Cplx1, complexin 1, [Score=57.0, Expect=2e-10]} {Dmel: FBgn0041605, cpx, complexin, [Score=66.2, Expect=9e-14]} {Celegans: WBGene00022271, cpx-1, Putative complexin-1, [Score=77.8, Expect=2e-18]} {Smed: dd_Smed_v6_9918_0_1, dd_Smed_v6_9918_0_1, [Score=91.7, Expect=6e-24]} {RNA1310_47061} |
7. | MligTC455_09224 | 21 | 0.43 | Mlig455_038078 | Neo: - Age: - |
0.997 | - | - | - | - | - | 0.997 | Mlig455_038078 {REF} {Length: 771} {Pfam: PAN domain [PF00024.28, score=28.0]} {RNA1509_46267} {RNA1310_51656} {RNA815_32275.1} | |
8. | MligTC455_13975 | 63 | 1.31 | Mlig455_070810 | Neo: - Age: - Region-enriched R2: 7.513/0.00519 |
0.997 | - | - | - | - | - | 0.997 | Mlig455_070810 {REF} {Length: 1542} {Pfam: Otopetrin [PF03189.15, score=108.9]} {Dmel: FBgn0031514, CG3332, [Score=74.3, Expect=3e-14]} {Celegans: WBGene00015035, otpl-1, OToPetrin-Like, [Score=47.8, Expect=9e-06]} {Smed: dd_Smed_v6_13612_0_3, dd_Smed_v6_13612_0_3, [Score=119, Expect=2e-29]} {RNA1310_93602} {RNA815_48323} | |
9. | MligTC455_01256 | 9 | 0.19 | Mlig455_019247 | Neo: - Age: - |
0.994 | - | - | - | - | - | 0.994 | Mlig455_019247 {REF} {Length: 889} {Celegans: WBGene00020795, T25D1.3, [Score=47.4, Expect=2e-07]} {RNA1310_599.2} | |
10. | MligTC455_21502 | 36 | 0.75 | Mlig455_018529 | Neo: - Age: - Region-enriched R2: 5.380/0.01311 |
0.993 | - | - | - | - | - | 0.993 | Mlig455_018529 {REF} {Length: 1004} {Pfam: Fas apoptotic inhibitory molecule (FAIM1) [PF06905.15, score=43.7]} {Mouse: ENSMUSG00000032463, Faim, Fas apoptotic inhibitory molecule, [Score=54.7, Expect=2e-09]} {Smed: dd_Smed_v6_4798_0_1, dd_Smed_v6_4798_0_1, [RH, Score=75.1, Expect=7e-18]} {RNA1310_42034} {RNA815_19884} | |
11. | MligTC455_26471 | 119 | 2.47 | Mlig455_050266 | Neo: Neoblast, stringent Age: Up-Down-Down |
PUM3 | 0.993 | - | - | 0.993 | - | - | - | Mlig455_050266 {REF} {Length: 4249} {TRANSSPLICED} {Pfam: CPL (NUC119) domain [PF08144.13, score=55.2]; Pumilio-family RNA binding repeat [PF00806.21, score=24.5]} {Human: ENSG00000080608, PUM3, pumilio RNA binding family member 3, [RH, Score=210, Expect=4e-58]} {Mouse: ENSMUSG00000041360, Pum3, pumilio RNA-binding family member 3, [RH, Score=217, Expect=9e-61]} {Dmel: FBgn0015527, peng, penguin, [RH, Score=127, Expect=4e-30]} {Celegans: WBGene00014165, puf-12, Pumilio domain-containing protein 12, [RH, Score=204, Expect=2e-55]} {Smed: dd_Smed_v6_7389_0_1, dd_Smed_v6_7389_0_1, [RH, Score=221, Expect=7e-63]} {RNA1509_8112} {RNA1310_6869.1} {RNA815_1829.1} |
12. | MligTC455_33832 | 112 | 2.34 | Mlig455_029411 | Neo: - Age: Up-Down-Down Region-enriched R2: 5.300/0.00016 |
GLRA3 | 0.993 | - | - | - | - | - | 0.993 | Mlig455_029411 {REF} {Length: 3686} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=149.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=84.5]} {Human: ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=257, Expect=5e-80]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [Score=253, Expect=3e-78]; ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=250, Expect=4e-77]} {Mouse: ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=251, Expect=2e-77]; ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=249, Expect=5e-77]; ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [Score=248, Expect=2e-76]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [Score=243, Expect=1e-74]} {Dmel: FBgn0024963, GluClalpha, [Score=253, Expect=2e-78]} {Celegans: WBGene00000233, avr-15, GluClalpha2B protein, [Score=259, Expect=7e-81]} {Smed: dd_Smed_v6_11342_0_1, dd_Smed_v6_11342_0_1, [RH, Score=480, Expect=1e-167]} {RNA1509_35986} {RNA1310_35528} {RNA815_35433} |
13. | MligTC455_43324 | 71 | 1.47 | Mlig455_041984 | Neo: - Age: - Region-enriched R2: 6.623/0.00573 |
0.993 | - | - | - | - | - | 0.993 | Mlig455_041984 {REF} {Length: 388} {NoTransDecoderORF} {RNA1509_49821} {RNA1310_52560.2} {RNA815_59873} | |
14. | MligTC455_45349 | 19 | 0.39 | Mlig455_068174 | Neo: - Age: - |
0.993 | - | - | - | - | - | 0.993 | Mlig455_068174 {REF} {Length: 495} {NoTransDecoderORF} | |
15. | MligTC455_09470 | 14 | 0.29 | Mlig455_034931 | Neo: - Age: - |
0.992 | - | - | - | - | - | 0.992 | Mlig455_034931 {REF} {Length: 484} {NoTransDecoderORF} {RNA1310_124147} | |
16. | MligTC455_14107 | 77 | 1.61 | Mlig455_025350, Mlig455_025394 | Neo: - Age: - Region-enriched R2: 10.212/0.00000 |
0.992 | - | - | - | - | - | 0.992 | Mlig455_025350 {REF} {Length: 568} {RNA1310_64375} {RNA815_39588} Mlig455_025394 {REF} {Length: 749} {RNA1509_58356} {RNA1310_64375} {RNA815_39588} |
|
17. | MligTC455_25410 | 47 | 0.97 | Mlig455_026185 | Neo: - Age: Up-Down-Down Region-enriched R2: 8.036/0.00469 |
0.992 | - | - | - | - | - | 0.992 | Mlig455_026185 {REF} {Length: 3002} {Pfam: Variant SH3 domain [PF07653.19, score=19.6]; Growth-arrest specific micro-tubule binding [PF13851.8, score=19.3]} {Mouse: ENSMUSG00000034156, Tspoap1, TSPO associated protein 1, [Score=54.7, Expect=6e-07]} {Smed: dd_Smed_v6_14584_0_1, dd_Smed_v6_14584_0_1, [Score=140, Expect=7e-35]} {RNA1509_45271} {RNA1310_5741} {RNA815_46868} | |
18. | MligTC455_53346 | 17 | 0.35 | Mlig455_010821, Mlig455_010828 | Neo: - Age: Up-Down-Down |
CNGA3 | 0.992 | - | - | 0.992 | - | - | - | Mlig455_010821 {REF} {Length: 2277} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=67.8]; C-terminal leucine zipper domain of cyclic nucleotide-gated channels [PF16526.7, score=60.3]; Ion transport protein [PF00520.33, score=50.1]} {Human: ENSG00000144191, CNGA3, cyclic nucleotide gated channel alpha 3, [Score=614, Expect=0.0]} {Mouse: ENSMUSG00000026114, Cnga3, cyclic nucleotide gated channel alpha 3, [Score=609, Expect=0.0]} {Dmel: FBgn0261612, CngA, Cyclic nucleotide-gated ion channel subunit A, [Score=559, Expect=0.0]} {Celegans: WBGene00006526, tax-4, Cyclic nucleotide-gated cation channel, [Score=538, Expect=0.0]} {Smed: dd_Smed_v6_22398_0_1, dd_Smed_v6_22398_0_1, [Score=629, Expect=0.0]} {RNA1310_57933} {RNA815_59167} Mlig455_010828 {REF} {Length: 794} {Pfam: C-terminal leucine zipper domain of cyclic nucleotide-gated channels [PF16526.7, score=45.0]; Cyclic nucleotide-binding domain [PF00027.31, score=27.6]} {Human: ENSG00000144191, CNGA3, cyclic nucleotide gated channel alpha 3, [Score=219, Expect=1e-66]} {Mouse: ENSMUSG00000026114, Cnga3, cyclic nucleotide gated channel alpha 3, [Score=214, Expect=8e-65]} {Dmel: FBgn0261612, CngA, Cyclic nucleotide-gated ion channel subunit A, [Score=205, Expect=2e-61]} {Celegans: WBGene00006526, tax-4, Cyclic nucleotide-gated cation channel, [Score=216, Expect=4e-65]} {Smed: dd_Smed_v6_22398_0_1, dd_Smed_v6_22398_0_1, [Score=249, Expect=1e-78]} {RNA1310_57933} {RNA815_16119} |
19. | MligTC455_36194 | 30 | 0.61 | Mlig455_064360, Mlig455_064382 | Neo: - Age: - |
B3GNT4 | 0.989 | - | - | - | - | - | 0.989 | Mlig455_064360 {REF} {Length: 3119} {Pfam: Galactosyltransferase [PF01762.23, score=116.7]} {Human: ENSG00000176383, B3GNT4, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4, [Score=101, Expect=5e-23]} {Mouse: ENSMUSG00000031803, B3gnt3, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3, [Score=94.7, Expect=9e-21]; ENSMUSG00000051650, B3gnt2, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2, [Score=94.0, Expect=2e-20]; ENSMUSG00000067370, B3galt4, UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4, [Score=93.6, Expect=3e-20]; ENSMUSG00000029431, B3gnt4, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4, [Score=93.2, Expect=2e-20]; ENSMUSG00000022686, B3gnt5, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5, [Score=91.7, Expect=1e-19]} {Dmel: FBgn0031988, CG8668, [Score=90.1, Expect=8e-19]} {Celegans: WBGene00007104, B0024.15, Hexosyltransferase, [RH, Score=90.9, Expect=8e-20]} {Smed: dd_Smed_v6_9789_0_1, dd_Smed_v6_9789_0_1, [Score=165, Expect=5e-47]} {RNA1310_43172} {RNA815_26726} Mlig455_064382 {REF} {Length: 3084} {Pfam: Galactosyltransferase [PF01762.23, score=116.7]} {Human: ENSG00000176383, B3GNT4, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4, [Score=101, Expect=5e-23]} {Mouse: ENSMUSG00000031803, B3gnt3, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3, [Score=94.7, Expect=9e-21]; ENSMUSG00000051650, B3gnt2, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2, [Score=94.4, Expect=2e-20]; ENSMUSG00000029431, B3gnt4, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4, [Score=93.6, Expect=2e-20]; ENSMUSG00000067370, B3galt4, UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4, [Score=93.6, Expect=2e-20]; ENSMUSG00000022686, B3gnt5, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5, [Score=92.0, Expect=9e-20]} {Dmel: FBgn0031988, CG8668, [Score=90.1, Expect=8e-19]} {Celegans: WBGene00007104, B0024.15, Hexosyltransferase, [RH, Score=90.9, Expect=8e-20]} {Smed: dd_Smed_v6_9789_0_1, dd_Smed_v6_9789_0_1, [Score=165, Expect=5e-47]} {RNA1310_43172} {RNA815_26726} |
20. | MligTC455_43322 | 67 | 1.4 | Mlig455_032888 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.946 Region-enriched R2: 7.587/0.00001 |
0.988 | - | - | - | - | - | 0.988 | Mlig455_032888 {REF} {Length: 2179} {RNA1509_40507, RNA1509_49821} {RNA1310_22780, RNA1509_40507} {RNA1509_40507, RNA815_9762} | |
21. | MligTC455_47393 | 241 | 5.03 | Mlig455_008718, Mlig455_063579 | Neo: - Age: Down-Up-Down Region-enriched R2: 3.683/0.00849 |
CALM2 | 0.988 | - | - | - | - | - | 0.988 | Mlig455_008718 {REF} {Length: 1727} {Pfam: EF hand [PF00036.34, score=99.3]; EF-hand domain pair [PF13499.8, score=95.1]; EF-hand domain [PF13405.8, score=86.1]; EF-hand domain pair [PF13833.8, score=76.8]; EF hand [PF13202.8, score=75.3]; EF-hand domain [PF14658.8, score=46.0]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=38.5]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=27.9]; EF-hand domain [PF08976.13, score=23.4]; Uncharacterised protein family (UPF0154) [PF03672.15, score=18.7]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=108, Expect=4e-30]; ENSG00000160014, CALM3, calmodulin 3, [Score=108, Expect=4e-30]; ENSG00000198668, CALM1, calmodulin 1, [Score=108, Expect=4e-30]} {Mouse: ENSMUSG00000019370, Calm3, calmodulin 3, [Score=108, Expect=2e-30]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=108, Expect=2e-30]; ENSMUSG00000001175, Calm1, calmodulin 1, [Score=108, Expect=2e-30]; ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=106, Expect=1e-29]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=107, Expect=3e-30]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=107, Expect=2e-30]} {Smed: dd_Smed_v6_3441_0_1, dd_Smed_v6_3441_0_1, [Score=114, Expect=8e-33]} {RNA1310_33847.1} {RNA815_17211} Mlig455_063579 {REF} {Length: 2562} {Pfam: EF hand [PF00036.34, score=95.8]; EF-hand domain pair [PF13499.8, score=92.8]; EF-hand domain [PF13405.8, score=82.9]; EF-hand domain pair [PF13833.8, score=74.4]; EF hand [PF13202.8, score=72.2]; EF-hand domain [PF14658.8, score=43.8]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=38.5]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=25.6]; EF-hand domain [PF08976.13, score=21.4]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=111, Expect=7e-30]; ENSG00000198668, CALM1, calmodulin 1, [Score=108, Expect=3e-29]; ENSG00000160014, CALM3, calmodulin 3, [Score=108, Expect=3e-29]} {Mouse: ENSMUSG00000001175, Calm1, calmodulin 1, [Score=111, Expect=7e-30]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=108, Expect=2e-29]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=108, Expect=2e-29]; ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=106, Expect=9e-29]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=107, Expect=3e-29]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=107, Expect=2e-29]} {Smed: dd_Smed_v6_3441_0_1, dd_Smed_v6_3441_0_1, [Score=111, Expect=9e-31]} {RNA1310_12431.1} {RNA815_17211} |
22. | MligTC455_12367 | 21 | 0.43 | Mlig455_018415 | Neo: - Age: - |
0.986 | - | - | - | - | - | 0.986 | Mlig455_018415 {REF} {Length: 1087} {NoTransDecoderORF} {RNA1509_40947} {RNA1310_134428} {RNA815_6067.1} | |
23. | MligTC455_19876 | 135 | 2.82 | Mlig455_024520, Mlig455_024523 | Neo: - Age: - |
0.986 | - | - | - | - | - | 0.986 | Mlig455_024520 {REF} {Length: 2352} {Pfam: CD20-like family [PF04103.17, score=40.9]} {Mouse: ENSMUSG00000048004, Tmem196, transmembrane protein 196, [Score=63.5, Expect=2e-12]} {Smed: dd_Smed_v6_14043_0_1, dd_Smed_v6_14043_0_1, [Score=184, Expect=5e-59]} {RNA1509_25506} {RNA1310_9338} {RNA815_23744} Mlig455_024523 {REF} {Length: 2311} {Smed: dd_Smed_v6_14043_0_1, dd_Smed_v6_14043_0_1, [Score=153, Expect=3e-47]} {RNA1509_25506} {RNA1310_9338} {RNA815_23744} |
|
24. | MligTC455_17804 | 27 | 0.56 | Mlig455_069447 | Neo: - Age: - |
0.985 | - | - | - | - | - | 0.985 | Mlig455_069447 {REF} {Length: 955} {RNA1310_40722} {RNA815_46396} | |
25. | MligTC455_30159 | 107 | 2.22 | Mlig455_008465, Mlig455_009916 | Neo: - Age: Up-Down-Down Region-enriched R2: 4.961/0.00498 |
TCF7L1 | 0.985 | - | - | - | - | - | 0.985 | Mlig455_008465 {REF} {Length: 2454} {Pfam: HMG (high mobility group) box [PF00505.21, score=81.3]; HMG-box domain [PF09011.12, score=34.6]} {Human: ENSG00000152284, TCF7L1, transcription factor 7 like 1, [RH, Score=161, Expect=7e-43]; ENSG00000138795, LEF1, lymphoid enhancer binding factor 1, [RH, Score=159, Expect=3e-43]; ENSG00000081059, TCF7, transcription factor 7, [RH, Score=156, Expect=8e-42]} {Mouse: ENSMUSG00000055799, Tcf7l1, transcription factor 7 like 1 (T cell specific, HMG box), [RH, Score=161, Expect=4e-43]; ENSMUSG00000027985, Lef1, lymphoid enhancer binding factor 1, [RH, Score=159, Expect=4e-44]; ENSMUSG00000000782, Tcf7, transcription factor 7, T cell specific, [RH, Score=155, Expect=6e-43]} {Dmel: FBgn0085432, pan, pangolin, [RH, Score=157, Expect=4e-41]} {Celegans: WBGene00004077, pop-1, [Score=108, Expect=2e-25]} {Smed: dd_Smed_v6_34144_0_1, dd_Smed_v6_34144_0_1, [RH, Score=166, Expect=2e-48]} {RNA1310_11181} {RNA815_36690} Mlig455_009916 {REF} {Length: 2137} {Pfam: HMG (high mobility group) box [PF00505.21, score=81.4]; HMG-box domain [PF09011.12, score=34.7]} {Human: ENSG00000152284, TCF7L1, transcription factor 7 like 1, [RH, Score=161, Expect=4e-43]; ENSG00000138795, LEF1, lymphoid enhancer binding factor 1, [RH, Score=159, Expect=2e-43]; ENSG00000081059, TCF7, transcription factor 7, [RH, Score=157, Expect=5e-42]} {Mouse: ENSMUSG00000055799, Tcf7l1, transcription factor 7 like 1 (T cell specific, HMG box), [RH, Score=162, Expect=2e-43]; ENSMUSG00000027985, Lef1, lymphoid enhancer binding factor 1, [RH, Score=159, Expect=3e-44]; ENSMUSG00000000782, Tcf7, transcription factor 7, T cell specific, [RH, Score=155, Expect=4e-43]} {Dmel: FBgn0085432, pan, pangolin, [RH, Score=157, Expect=3e-41]} {Celegans: WBGene00004077, pop-1, [Score=108, Expect=2e-25]} {Smed: dd_Smed_v6_34144_0_1, dd_Smed_v6_34144_0_1, [RH, Score=166, Expect=1e-48]} {RNA1310_11181} {RNA815_36690} |
26. | MligTC455_33434 | 48 | 1 | Mlig455_015085, Mlig455_047128 | Neo: - Age: - |
VEZF1 | 0.985 | - | - | 0.985 | - | - | - | Mlig455_015085 {REF} {Length: 2879} {Mouse: ENSMUSG00000020396, Nefh, neurofilament, heavy polypeptide, [Score=54.3, Expect=3e-07]} {RNA1509_12203} {RNA1310_1239} {RNA815_9387} Mlig455_047128 {REF} {Length: 3786} {Human: ENSG00000136451, VEZF1, vascular endothelial zinc finger 1, [Score=51.6, Expect=3e-06]} {Mouse: ENSMUSG00000020396, Nefh, neurofilament, heavy polypeptide, [Score=82.4, Expect=2e-15]} {Smed: dd_Smed_v6_9974_1_8, dd_Smed_v6_9974_1_8, [Score=60.8, Expect=2e-09]} {RNA1509_12203} {RNA1310_718} {RNA815_9387} |
27. | MligTC455_48521 | 56 | 1.17 | Mlig455_004444 | Neo: - Age: - |
0.985 | - | - | - | - | - | 0.985 | Mlig455_004444 {REF} {Length: 3968} {Pfam: GDNF/GAS1 domain [PF02351.18, score=19.4]} {Smed: dd_Smed_v6_19517_0_1, dd_Smed_v6_19517_0_1, [RH, Score=111, Expect=3e-25]} {RNA1509_50708} {RNA1310_13399} {RNA815_27009} | |
28. | MligTC455_53546 | 130 | 2.72 | Mlig455_013326, Mlig455_013334 | Neo: - Age: - Region-enriched R2: 6.753/0.01892 |
MMP9 | 0.985 | - | - | - | - | - | 0.985 | Mlig455_013326 {REF} {Length: 1449} {Pfam: Fibronectin type II domain [PF00040.21, score=92.5]} {Human: ENSG00000100985, MMP9, matrix metallopeptidase 9, [RH, Score=87.8, Expect=3e-18]} {Mouse: ENSMUSG00000017737, Mmp9, matrix metallopeptidase 9, [RH, Score=82.4, Expect=1e-16]; ENSMUSG00000031740, Mmp2, matrix metallopeptidase 2, [RH, Score=78.6, Expect=2e-15]} {Smed: dd_Smed_v6_14558_0_1, dd_Smed_v6_14558_0_1, [RH, Score=138, Expect=3e-38]} {RNA1310_38631} {RNA815_51136} Mlig455_013334 {REF} {Length: 1398} {Pfam: Fibronectin type II domain [PF00040.21, score=92.1]} {Human: ENSG00000100985, MMP9, matrix metallopeptidase 9, [RH, Score=89.4, Expect=1e-18]} {Mouse: ENSMUSG00000017737, Mmp9, matrix metallopeptidase 9, [RH, Score=84.0, Expect=4e-17]} {Smed: dd_Smed_v6_12601_0_1, dd_Smed_v6_12601_0_1, [RH, Score=140, Expect=2e-38]} {RNA1310_38631} {RNA815_51136} |
29. | MligTC455_19279 | 4576 | 95.33 | Mlig455_057411 | Neo: - Age: Down-Down-Up, logFC(26M/2M)=-0.654 Region-specific R2: 5.173 Region-enriched R2: 4.585/0.00000 |
CHRNA10 | 0.984 | - | - | - | - | - | 0.984 | Mlig455_057411 {REF} {Length: 1075} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=85.3]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=91.3, Expect=1e-20]} {Mouse: ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=92.0, Expect=7e-21]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=88.2, Expect=1e-19]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=110, Expect=2e-27]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=120, Expect=4e-31]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=96.3, Expect=8e-23]} {RNA1509_1306} {RNA1310_34970} {RNA815_15305.1} |
30. | MligTC455_45031 | 6 | 0.12 | Mlig455_018753 | Neo: - Age: - |
0.984 | - | - | - | - | - | 0.984 | Mlig455_018753 {REF} {Length: 1240} {RNA1509_46869} {RNA1310_21302} {RNA815_22307} | |
31. | MligTC455_23278 | 386 | 8.04 | Mlig455_037778 | Neo: - Age: logFC(26M/2M)=-0.605 |
SLC13A3 | 0.983 | - | - | - | - | - | 0.983 | Mlig455_037778 {REF} {Length: 3476} {Pfam: Sodium:sulfate symporter transmembrane region [PF00939.21, score=294.2]; Citrate transporter [PF03600.18, score=99.7]} {Human: ENSG00000158296, SLC13A3, solute carrier family 13 member 3, [Score=377, Expect=4e-121]} {Mouse: ENSMUSG00000018459, Slc13a3, solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 3, [Score=367, Expect=1e-117]; ENSMUSG00000001095, Slc13a2, solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2, [Score=359, Expect=9e-115]} {Dmel: FBgn0036816, Indy, I'm not dead yet, [Score=175, Expect=1e-46]} {Celegans: WBGene00007138, B0285.6, Uncharacterized transporter B0285.6, [Score=194, Expect=2e-53]} {Smed: dd_Smed_v6_5476_0_1, dd_Smed_v6_5476_0_1, [Score=315, Expect=3e-98]} {RNA1509_1723, RNA1509_48306} {RNA1310_5497, RNA1509_48306} {RNA1509_48306, RNA815_1709} |
32. | MligTC455_41399 | 147 | 3.07 | Mlig455_028472, Mlig455_028497 | Neo: - Age: - Region-enriched R4: 3.401/0.01137 |
FADS2 | 0.983 | - | - | - | - | - | 0.983 | Mlig455_028472 {REF} {Length: 2155} {Pfam: Fatty acid desaturase [PF00487.26, score=111.7]} {Human: ENSG00000134824, FADS2, fatty acid desaturase 2, [Score=348, Expect=8e-118]; ENSG00000149485, FADS1, fatty acid desaturase 1, [Score=339, Expect=4e-115]} {Mouse: ENSMUSG00000024665, Fads2, fatty acid desaturase 2, [Score=357, Expect=4e-121]} {Celegans: WBGene00001395, fat-3, Delta(6)-fatty-acid desaturase fat-3, [Score=107, Expect=1e-26]} {Smed: dd_Smed_v6_10869_0_1, dd_Smed_v6_10869_0_1, [Score=418, Expect=1e-145]} {RNA1509_26943} {RNA1310_8517.1} {RNA815_15928} Mlig455_028497 {REF} {Length: 2199} {TRANSSPLICED} {Pfam: Fatty acid desaturase [PF00487.26, score=113.5]; Cytochrome b5-like Heme/Steroid binding domain [PF00173.30, score=60.8]} {Human: ENSG00000134824, FADS2, fatty acid desaturase 2, [Score=409, Expect=5e-140]; ENSG00000149485, FADS1, fatty acid desaturase 1, [Score=402, Expect=3e-136]} {Mouse: ENSMUSG00000024665, Fads2, fatty acid desaturase 2, [Score=422, Expect=4e-145]} {Dmel: FBgn0264294, Cyt-b5, Cytochrome b5, [Score=47.0, Expect=3e-06]} {Celegans: WBGene00001395, fat-3, Delta(6)-fatty-acid desaturase fat-3, [Score=121, Expect=4e-30]} {Smed: dd_Smed_v6_10869_0_1, dd_Smed_v6_10869_0_1, [RH, Score=476, Expect=3e-167]} {RNA1509_26943} {RNA1310_8517.1} {RNA815_15928} |
33. | MligTC455_53414 | 331 | 6.9 | Mlig455_053442 | Neo: - Age: - Region-specific R2: 4.308 Region-enriched R2: 3.374/0.00040 |
RP1 | 0.983 | - | - | - | - | - | 0.983 | Mlig455_053442 {REF} {Length: 1156} {Pfam: PLAT/LH2 domain [PF01477.25, score=155.8]; Doublecortin [PF03607.19, score=103.5]; Embryo-specific protein 3, (ATS3) [PF06232.13, score=22.0]} {Human: ENSG00000104237, RP1, RP1, axonemal microtubule associated, [Score=473, Expect=5e-146]} {Mouse: ENSMUSG00000025900, Rp1, retinitis pigmentosa 1 (human), [Score=454, Expect=1e-136]} {Dmel: FBgn0261387, CG17528, [Score=56.6, Expect=1e-07]} {Celegans: WBGene00006993, zyg-8, Serine/threonine-protein kinase zyg-8, [Score=75.5, Expect=2e-13]} {Smed: dd_Smed_v6_10315_0_2, dd_Smed_v6_10315_0_2, [Score=698, Expect=0.0]} {RNA1509_21828} {RNA1310_33070.1} {RNA815_13802.1} |
34. | MligTC455_24270 | 71 | 1.47 | Mlig455_005120 | Neo: - Age: - |
CHRNA7 | 0.982 | - | - | - | - | - | 0.982 | Mlig455_005120 {REF} {Length: 1530} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=115.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=66.6]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=148, Expect=4e-39]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=147, Expect=5e-39]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=145, Expect=4e-38]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=146, Expect=2e-38]; ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=140, Expect=1e-36]} {Dmel: FBgn0028875, nAChRalpha5, nicotinic Acetylcholine Receptor alpha5, [Score=135, Expect=5e-34]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=134, Expect=9e-35]} {Smed: dd_Smed_v6_8058_0_1, dd_Smed_v6_8058_0_1, [Score=133, Expect=4e-34]} {RNA1509_43533} {RNA1310_20839.2} {RNA815_22406} |
35. | MligTC455_53415 | 319 | 6.64 | Mlig455_053444 | Neo: - Age: Up-Down-Down Region-specific R2: 4.862 Region-enriched R2: 4.179/0.00011 |
RP1 | 0.982 | - | - | - | - | - | 0.982 | Mlig455_053444 {REF} {Length: 4944} {Pfam: PLAT/LH2 domain [PF01477.25, score=155.3]; Doublecortin [PF03607.19, score=100.5]; Embryo-specific protein 3, (ATS3) [PF06232.13, score=22.5]; Fibroblast growth factor [PF00167.20, score=18.6]} {Human: ENSG00000104237, RP1, RP1, axonemal microtubule associated, [Score=471, Expect=6e-145]} {Mouse: ENSMUSG00000025900, Rp1, retinitis pigmentosa 1 (human), [Score=453, Expect=3e-136]} {Dmel: FBgn0261387, CG17528, [Score=56.6, Expect=1e-07]} {Celegans: WBGene00006993, zyg-8, Serine/threonine-protein kinase zyg-8, [Score=75.9, Expect=1e-13]} {Smed: dd_Smed_v6_10315_0_2, dd_Smed_v6_10315_0_2, [Score=691, Expect=0.0]} {RNA1509_59703} {RNA1310_2710} {RNA815_17469} |
36. | MligTC455_03382 | 210 | 4.37 | Mlig455_057035 | Neo: - Age: - Region-enriched R2: 3.628/0.00113 |
PDE1C | 0.981 | - | - | - | - | - | 0.981 | Mlig455_057035 {REF} {Length: 2458} {Pfam: 3'5'-cyclic nucleotide phosphodiesterase [PF00233.21, score=275.1]; 3'5'-cyclic nucleotide phosphodiesterase N-terminal [PF08499.14, score=94.2]} {Human: ENSG00000154678, PDE1C, phosphodiesterase 1C, [RH, Score=546, Expect=0.0]} {Mouse: ENSMUSG00000004347, Pde1c, phosphodiesterase 1C, [RH, Score=546, Expect=0.0]} {Dmel: FBgn0264815, Pde1c, Phosphodiesterase 1c, [RH, Score=538, Expect=0.0]} {Celegans: WBGene00011433, pde-1, Probable 3',5'-cyclic phosphodiesterase pde-1, [RH, Score=482, Expect=2e-164]} {Smed: dd_Smed_v6_11039_0_2, dd_Smed_v6_11039_0_2, [RH, Score=613, Expect=0.0]} {RNA1509_46084} {RNA1310_8143.1} {RNA815_6002} |
37. | MligTC455_41153 | 61 | 1.28 | Mlig455_008928 | Neo: - Age: - |
0.981 | - | - | - | - | - | 0.981 | Mlig455_008928 {REF} {Length: 2067} {RNA1310_32232} {RNA815_16611} | |
38. | MligTC455_48520 | 46 | 0.96 | Mlig455_004433 | Neo: - Age: - |
0.981 | - | - | - | - | - | 0.981 | Mlig455_004433 {REF} {Length: 701} {RNA1310_56623} {RNA815_27009} | |
39. | MligTC455_50927 | 254 | 5.29 | Mlig455_070541, Mlig455_070562 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.296 Region-enriched R2: 7.883/0.00008 |
FZD4 | 0.981 | - | - | - | - | - | 0.981 | Mlig455_070541 {REF} {Length: 3522} {Pfam: Frizzled/Smoothened family membrane region [PF01534.19, score=339.1]; Fz domain [PF01392.24, score=88.1]} {Human: ENSG00000174804, FZD4, frizzled class receptor 4, [RH, Score=446, Expect=1e-149]} {Mouse: ENSMUSG00000049791, Fzd4, frizzled class receptor 4, [RH, Score=446, Expect=1e-149]} {Dmel: FBgn0001085, fz, frizzled, [Score=315, Expect=3e-98]} {Celegans: WBGene00000478, cfz-2, Frizzled-2, [Score=284, Expect=5e-87]} {Smed: dd_Smed_v6_7210_0_1, dd_Smed_v6_7210_0_1, [RH, Score=471, Expect=6e-159]} {RNA1509_15834} {RNA1310_3800, RNA1509_15834} {RNA1509_15834, RNA815_19571} Mlig455_070562 {REF} {Length: 3527} {Pfam: Frizzled/Smoothened family membrane region [PF01534.19, score=339.1]; Fz domain [PF01392.24, score=88.1]} {Human: ENSG00000174804, FZD4, frizzled class receptor 4, [RH, Score=446, Expect=1e-149]} {Mouse: ENSMUSG00000049791, Fzd4, frizzled class receptor 4, [RH, Score=446, Expect=2e-149]} {Dmel: FBgn0001085, fz, frizzled, [Score=315, Expect=3e-98]} {Celegans: WBGene00000478, cfz-2, Frizzled-2, [Score=284, Expect=5e-87]} {Smed: dd_Smed_v6_7210_0_1, dd_Smed_v6_7210_0_1, [RH, Score=470, Expect=8e-159]} {RNA1509_15834} {RNA1310_3800} {RNA815_19571} |
40. | MligTC455_22469 | 37 | 0.77 | Mlig455_052705 | Neo: - Age: logFC(26M/2M)=-1.003 |
GUK1 | 0.98 | - | - | - | - | - | 0.980 | Mlig455_052705 {REF} {Length: 1833} {Pfam: Guanylate kinase [PF00625.23, score=207.7]; AAA domain [PF13671.8, score=35.1]; 50S ribosome-binding GTPase [PF01926.25, score=28.4]; AAA domain [PF13238.8, score=26.9]; ABC transporter [PF00005.29, score=24.3]; AAA ATPase domain [PF13191.8, score=24.0]; AAA domain [PF13401.8, score=23.0]; P-loop containing region of AAA domain [PF13555.8, score=21.3]; RsgA GTPase [PF03193.18, score=20.4]; AAA domain, putative AbiEii toxin, Type IV TA system [PF13304.8, score=19.0]} {Human: ENSG00000143774, GUK1, guanylate kinase 1, [RH, Score=230, Expect=4e-77]} {Mouse: ENSMUSG00000020444, Guk1, guanylate kinase 1, [RH, Score=228, Expect=2e-76]} {Dmel: FBgn0036099, CG11811, [RH, Score=202, Expect=9e-66]} {Celegans: WBGene00020190, guk-1, GUanylate Kinase, [RH, Score=195, Expect=2e-63]} {Smed: dd_Smed_v6_4875_0_1, dd_Smed_v6_4875_0_1, [RH, Score=225, Expect=2e-75]} {RNA1509_30404} {RNA1310_39734} {RNA815_22943.1} |
41. | MligTC455_44578 | 12 | 0.24 | Mlig455_048995 | Neo: Int S/G2/M Age: - Region-enriched R2: 5.730/0.04221 |
0.98 | - | - | - | - | - | 0.980 | Mlig455_048995 {REF} {Length: 2090} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=110.0]} {RNA1310_22174} {RNA815_24783} | |
42. | MligTC455_45769 | 79 | 1.65 | Mlig455_018116 | Neo: - Age: - |
0.98 | - | - | - | - | - | 0.980 | Mlig455_018116 {REF} {Length: 3312} {Pfam: NACHT domain [PF05729.14, score=33.6]; AAA ATPase domain [PF13191.8, score=25.1]; AAA domain [PF13401.8, score=19.4]} {Smed: dd_Smed_v6_9074_0_1, dd_Smed_v6_9074_0_1, [Score=138, Expect=2e-33]} {RNA1509_44893} {RNA1310_38241} {RNA815_33748} | |
43. | MligTC455_54199 | 49 | 1.01 | Mlig455_034715, Mlig455_067590 | Neo: - Age: - Region-enriched R4: 5.064/0.03900 Regeneration-downregulated R4: -6.361 Regeneration-depleted R4: -6.361 |
0.98 | - | - | - | - | - | 0.980 | Mlig455_034715 {REF} {Length: 5399} {Pfam: PMP-22/EMP/MP20/Claudin family [PF00822.22, score=41.4]} {Smed: dd_Smed_v6_16515_0_1, dd_Smed_v6_16515_0_1, [Score=94.4, Expect=2e-21]} {RNA1310_64595} {RNA815_44335} Mlig455_067590 {REF} {Length: 3463} {Pfam: PMP-22/EMP/MP20/Claudin family [PF00822.22, score=27.2]} {Smed: dd_Smed_v6_20712_0_1, dd_Smed_v6_20712_0_1, [Score=74.3, Expect=5e-15]} {RNA1310_64595} {RNA815_44335} |
|
44. | MligTC455_14029 | 53 | 1.11 | Mlig455_022439 | Neo: - Age: - |
0.979 | - | - | - | - | - | 0.979 | Mlig455_022439 {REF} {Length: 2874} {RNA1509_36146} {RNA1310_30590} {RNA815_37384} | |
45. | MligTC455_43534 | 34 | 0.71 | Mlig455_030976 | Neo: - Age: - |
0.979 | - | - | - | - | - | 0.979 | Mlig455_030976 {REF} {Length: 1067} {RNA1310_40722} {RNA815_46396} | |
46. | MligTC455_09653 | 51 | 1.06 | Mlig455_044944 | Neo: - Age: - |
SLC17A6 | 0.978 | - | - | - | - | - | 0.978 | Mlig455_044944 {REF} {Length: 2769} {Pfam: Major Facilitator Superfamily [PF07690.18, score=118.9]} {Human: ENSG00000091664, SLC17A6, solute carrier family 17 member 6, [Score=260, Expect=4e-79]; ENSG00000104888, SLC17A7, solute carrier family 17 member 7, [Score=248, Expect=1e-74]} {Mouse: ENSMUSG00000030500, Slc17a6, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6, [Score=259, Expect=8e-79]; ENSMUSG00000070570, Slc17a7, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7, [Score=249, Expect=3e-75]; ENSMUSG00000019935, Slc17a8, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8, [Score=248, Expect=2e-74]} {Dmel: FBgn0031424, VGlut, Vesicular glutamate transporter, [Score=223, Expect=1e-64]} {Celegans: WBGene00001135, eat-4, Probable vesicular glutamate transporter eat-4, [Score=203, Expect=2e-58]} {Smed: dd_Smed_v6_21295_0_1, dd_Smed_v6_21295_0_1, [RH, Score=616, Expect=0.0]} {RNA1310_79790} {RNA815_45443} |
47. | MligTC455_19875 | 82 | 1.71 | Mlig455_024408 | Neo: - Age: Down-Up-Down |
0.978 | - | - | - | - | - | 0.978 | Mlig455_024408 {REF} {Length: 2479} {Pfam: CD20-like family [PF04103.17, score=40.9]} {Mouse: ENSMUSG00000048004, Tmem196, transmembrane protein 196, [Score=63.5, Expect=2e-12]} {Smed: dd_Smed_v6_14043_0_1, dd_Smed_v6_14043_0_1, [Score=184, Expect=5e-59]} {RNA1509_25506} {RNA1310_4968.1} {RNA815_23744} | |
48. | MligTC455_09723 | 43 | 0.89 | Mlig455_048052, Mlig455_048071 | Neo: - Age: Up-Down-Down |
0.977 | - | - | - | - | - | 0.977 | Mlig455_048052 {REF} {Length: 3592} {Pfam: Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=110.8]; 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=57.6]; Glycine rich protein family [PF07172.13, score=21.2]} {Dmel: FBgn0033579, CG13229, [Score=121, Expect=1e-29]} {Celegans: WBGene00016428, dmsr-7, DroMyoSuppressin Receptor related, [Score=135, Expect=2e-34]} {Smed: dd_Smed_v6_24203_0_1, dd_Smed_v6_24203_0_1, [Score=204, Expect=1e-60]} {RNA1509_18576} {RNA1310_81440} {RNA815_16348} Mlig455_048071 {REF} {Length: 4002} {Pfam: Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=110.0]; 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=58.2]; Glycine rich protein family [PF07172.13, score=21.9]} {Dmel: FBgn0033579, CG13229, [Score=119, Expect=5e-29]} {Celegans: WBGene00016428, dmsr-7, DroMyoSuppressin Receptor related, [Score=131, Expect=4e-33]} {Smed: dd_Smed_v6_24203_0_1, dd_Smed_v6_24203_0_1, [Score=202, Expect=8e-60]} {RNA1509_18576} {RNA1310_81440} {RNA815_16348} |
|
49. | MligTC455_51807 | 28 | 0.59 | Mlig455_046394 | Neo: - Age: - |
GPSM2 | 0.977 | - | - | - | - | - | 0.977 | Mlig455_046394 {REF} {Length: 3388} {Pfam: Tetratricopeptide repeat [PF13424.8, score=114.4]; Tetratricopeptide repeat [PF13176.8, score=96.0]; Tetratricopeptide repeat [PF00515.30, score=94.3]; GoLoco motif [PF02188.19, score=85.6]; Tetratricopeptide repeat [PF07719.19, score=55.0]; Tetratricopeptide repeat [PF13181.8, score=42.2]; Tetratricopeptide repeat [PF13374.8, score=32.8]; Rapsyn N-terminal myristoylation and linker region [PF10579.11, score=20.1]} {Human: ENSG00000121957, GPSM2, G protein signaling modulator 2, [RH, Score=542, Expect=0.0]} {Mouse: ENSMUSG00000027883, Gpsm2, G-protein signalling modulator 2 (AGS3-like, C. elegans), [RH, Score=532, Expect=1e-180]; ENSMUSG00000026930, Gpsm1, G-protein signalling modulator 1 (AGS3-like, C. elegans), [RH, Score=511, Expect=1e-172]} {Dmel: FBgn0040080, pins, partner of inscuteable, [RH, Score=530, Expect=2e-180]} {Celegans: WBGene00000092, ags-3, Activator of G protein Signalling, [RH, Score=266, Expect=7e-80]} {Smed: dd_Smed_v6_6548_1_1, dd_Smed_v6_6548_1_1, [RH, Score=477, Expect=1e-159]} {RNA1310_18538} {RNA815_41322} |
50. | MligTC455_10151 | 146 | 3.05 | Mlig455_068692, Mlig455_068719 | Neo: - Age: - |
KREMEN1 | 0.976 | - | - | - | - | - | 0.976 | Mlig455_068692 {REF} {Length: 1086} {Pfam: WSC domain [PF01822.21, score=56.5]} {Human: ENSG00000183762, KREMEN1, kringle containing transmembrane protein 1, [Score=45.4, Expect=7e-06]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=68.9, Expect=2e-14]} {RNA1310_42686} {RNA815_25047} Mlig455_068719 {REF} {Length: 1973} {TRANSSPLICED} {Pfam: WSC domain [PF01822.21, score=55.8]} {Human: ENSG00000183762, KREMEN1, kringle containing transmembrane protein 1, [Score=45.1, Expect=8e-06]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=67.0, Expect=8e-14]} {RNA1509_56630} {RNA1310_42686} {RNA815_25047} |
51. | MligTC455_43293 | 2619 | 54.57 | Mlig455_001393 | Neo: - Age: - Region-specific R2: 1.579 |
ANXA7 | 0.976 | - | - | - | - | - | 0.976 | Mlig455_001393 {REF} {Length: 4698} {Pfam: Annexin [PF00191.22, score=268.6]} {Human: ENSG00000138279, ANXA7, annexin A7, [RH, Score=307, Expect=6e-98]} {Mouse: ENSMUSG00000021814, Anxa7, annexin A7, [RH, Score=301, Expect=8e-96]} {Dmel: FBgn0000083, AnxB9, Annexin B9, [Score=259, Expect=4e-82]} {Celegans: WBGene00003589, nex-2, Annexin, [Score=261, Expect=2e-81]} {Smed: dd_Smed_v6_1735_0_1, dd_Smed_v6_1735_0_1, [Score=270, Expect=6e-86]} {RNA1509_5239} {RNA1310_11340, RNA1509_5239} {RNA1509_5239, RNA815_3977} |
52. | MligTC455_19079 | 218 | 4.54 | Mlig455_008746, Mlig455_008760 | Neo: - Age: Down-Up-Up Region-specific R2: 6.705 Region-enriched R2: 6.864/0.00152 |
0.975 | - | - | - | - | - | 0.975 | Mlig455_008746 {REF} {Length: 652} {RNA1310_75395.1} {RNA815_42524} Mlig455_008760 {REF} {Length: 1051} {RNA1310_75395.1} {RNA815_42524} |
|
53. | MligTC455_32366 | 22 | 0.45 | Mlig455_034995, Mlig455_056739 | Neo: - Age: - |
KREMEN2 | 0.975 | - | - | - | - | - | 0.975 | Mlig455_034995 {REF} {Length: 838} {Pfam: WSC domain [PF01822.21, score=57.3]; PAN domain [PF00024.28, score=30.2]} {Human: ENSG00000131650, KREMEN2, kringle containing transmembrane protein 2, [Score=48.9, Expect=2e-06]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=53.1, Expect=7e-08]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=64.7, Expect=6e-12]} {RNA1310_90615} {RNA815_32019} Mlig455_056739 {REF} {Length: 3691} {RNA1310_90615} {RNA815_24291.1} |
54. | MligTC455_12489 | 22 | 0.45 | Mlig455_004470 | Neo: - Age: - |
0.974 | - | - | 0.974 | - | - | - | Mlig455_004470 {REF} {Length: 1368} {Pfam: Lectin C-type domain [PF00059.23, score=24.8]} {RNA1310_22051} {RNA815_28288} | |
55. | MligTC455_13375 | 48 | 1 | Mlig455_008269 | Neo: - Age: - Region-enriched R2: 6.043/0.00338 |
0.974 | - | - | - | - | - | 0.974 | Mlig455_008269 {REF} {Length: 2598} {RNA1310_27894} {RNA815_60961} | |
56. | MligTC455_29681 | 43 | 0.89 | Mlig455_031785 | Neo: Irradiation |
ABCA5 | 0.974 | - | - | - | - | - | 0.974 | Mlig455_031785 {REF} {Length: 9241} {Pfam: ABC transporter [PF00005.29, score=177.5]; AAA domain, putative AbiEii toxin, Type IV TA system [PF13304.8, score=64.7]; ABC-2 family transporter protein [PF12698.9, score=47.4]; Mab-21 protein [PF03281.16, score=41.5]; Ankyrin repeats (3 copies) [PF12796.9, score=39.5]; Ankyrin repeats (many copies) [PF13637.8, score=36.7]; Ankyrin repeats (many copies) [PF13857.8, score=36.2]; RecF/RecN/SMC N terminal domain [PF02463.21, score=31.9]; Ankyrin repeat [PF00023.32, score=28.0]; Ankyrin repeat [PF13606.8, score=27.7]; RsgA GTPase [PF03193.18, score=26.0]; Putative exonuclease SbcCD, C subunit [PF13558.8, score=22.1]; P-loop containing region of AAA domain [PF13555.8, score=20.9]; Domain of unknown function (DUF4162) [PF13732.8, score=20.7]; AAA ATPase domain [PF13175.8, score=19.4]; 50S ribosome-binding GTPase [PF01926.25, score=19.2]} {Human: ENSG00000154265, ABCA5, ATP binding cassette subfamily A member 5, [Score=241, Expect=4e-63]; ENSG00000154263, ABCA10, ATP binding cassette subfamily A member 10, [Score=241, Expect=2e-63]; ENSG00000141338, ABCA8, ATP binding cassette subfamily A member 8, [Score=237, Expect=6e-62]; ENSG00000154258, ABCA9, ATP binding cassette subfamily A member 9, [Score=230, Expect=1e-59]} {Mouse: ENSMUSG00000018800, Abca5, ATP-binding cassette, sub-family A (ABC1), member 5, [Score=231, Expect=4e-60]; ENSMUSG00000041828, Abca8a, ATP-binding cassette, sub-family A (ABC1), member 8a, [Score=227, Expect=5e-59]; ENSMUSG00000041797, Abca9, ATP-binding cassette, sub-family A (ABC1), member 9, [Score=225, Expect=2e-58]; ENSMUSG00000020620, Abca8b, ATP-binding cassette, sub-family A (ABC1), member 8b, [Score=223, Expect=6e-58]} {Dmel: FBgn0031170, CG1718, [Score=204, Expect=5e-52]} {Celegans: WBGene00000022, abt-4, ABC Transporter family, [Score=214, Expect=2e-55]} {Smed: dd_Smed_v6_2300_0_2, dd_Smed_v6_2300_0_2, [Score=214, Expect=3e-55]} {RNA1509_10079} {RNA1310_978} {RNA815_1686} |
57. | MligTC455_32028 | 19 | 0.39 | Mlig455_019343, Mlig455_019346 | Neo: - Age: - |
GRIA2 | 0.973 | - | - | - | - | - | 0.973 | Mlig455_019343 {REF} {Length: 3241} {Pfam: Ligand-gated ion channel [PF00060.28, score=96.6]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=57.9]; Receptor family ligand binding region [PF01094.30, score=49.1]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=19.0]} {Human: ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [Score=150, Expect=1e-36]; ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=149, Expect=2e-36]; ENSG00000155511, GRIA1, glutamate ionotropic receptor AMPA type subunit 1, [Score=146, Expect=2e-35]; ENSG00000152578, GRIA4, glutamate ionotropic receptor AMPA type subunit 4, [Score=144, Expect=9e-35]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=144, Expect=1e-34]} {Mouse: ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=150, Expect=5e-37]; ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [Score=150, Expect=8e-37]; ENSMUSG00000020524, Gria1, glutamate receptor, ionotropic, AMPA1 (alpha 1), [Score=145, Expect=3e-35]; ENSMUSG00000025892, Gria4, glutamate receptor, ionotropic, AMPA4 (alpha 4), [Score=145, Expect=3e-35]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=144, Expect=5e-35]} {Dmel: FBgn0039927, CG11155, [Score=158, Expect=1e-39]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=125, Expect=3e-29]} {Smed: dd_Smed_v6_31078_0_1, dd_Smed_v6_31078_0_1, [Score=250, Expect=2e-75]} {RNA1509_10728} {RNA1310_4026} {RNA815_8415.1} Mlig455_019346 {REF} {Length: 519} {Pfam: Receptor family ligand binding region [PF01094.30, score=21.5]} {RNA1509_10728} {RNA1310_4026} {RNA815_8415.2} |
58. | MligTC455_34738 | 836 | 17.41 | Mlig455_032157, Mlig455_032163, Mlig455_067631 | Neo: - Age: - |
0.973 | - | - | - | - | - | 0.973 | Mlig455_032157 {REF} {Length: 1841} {Pfam: Stathmin family [PF00836.21, score=49.5]} {Smed: dd_Smed_v6_512_0_1, dd_Smed_v6_512_0_1, [RH, Score=80.5, Expect=2e-21]} {RNA1509_18048, RNA1509_6791} {RNA1310_32272, RNA1509_18048, RNA1509_6791} {RNA1509_18048, RNA1509_6791, RNA815_831} Mlig455_032163 {REF} {Length: 1001} {Pfam: Stathmin family [PF00836.21, score=44.6]} {Smed: dd_Smed_v6_512_0_1, dd_Smed_v6_512_0_1, [RH, Score=84.0, Expect=3e-22]} {RNA1509_6791} {RNA1310_71333} {RNA815_831} Mlig455_067631 {REF} {Length: 817} {Pfam: Stathmin family [PF00836.21, score=31.3]} {RNA1509_6791} {RNA1310_71333} {RNA815_831} |
|
59. | MligTC455_41724 | 23 | 0.49 | Mlig455_001647 | Neo: - |
0.973 | - | - | - | - | - | 0.973 | Mlig455_001647 {REF} {Length: 1808} {RNA1310_22665} {RNA815_13308} | |
60. | MligTC455_53860 | 202 | 4.22 | Mlig455_053523, Mlig455_061000 | Neo: - Age: Up-Down-Down Region-enriched R2: 3.086/0.02665 |
RGS3 | 0.973 | - | - | - | - | - | 0.973 | Mlig455_053523 {REF} {Length: 2125} {Pfam: Regulator of G protein signaling domain [PF00615.21, score=117.0]} {Human: ENSG00000138835, RGS3, regulator of G protein signaling 3, [RH, Score=163, Expect=4e-45]} {Mouse: ENSMUSG00000059810, Rgs3, regulator of G-protein signaling 3, [RH, Score=165, Expect=2e-45]} {Dmel: FBgn0028743, Dhit, Double hit, [Score=109, Expect=2e-27]} {Celegans: WBGene00004350, rgs-7, Regulator of G-protein signaling rgs-7, [RH, Score=130, Expect=1e-34]} {Smed: dd_Smed_v6_8787_0_1, dd_Smed_v6_8787_0_1, [Score=173, Expect=9e-51]} {RNA1310_19330.1} {RNA815_18723} Mlig455_061000 {REF} {Length: 2721} {Pfam: Regulator of G protein signaling domain [PF00615.21, score=117.0]; Dehydrin [PF00257.21, score=20.5]} {Human: ENSG00000138835, RGS3, regulator of G protein signaling 3, [RH, Score=163, Expect=4e-45]} {Mouse: ENSMUSG00000059810, Rgs3, regulator of G-protein signaling 3, [RH, Score=165, Expect=2e-45]} {Dmel: FBgn0028743, Dhit, Double hit, [Score=109, Expect=2e-27]} {Celegans: WBGene00004350, rgs-7, Regulator of G-protein signaling rgs-7, [RH, Score=130, Expect=1e-34]} {Smed: dd_Smed_v6_8787_0_1, dd_Smed_v6_8787_0_1, [Score=173, Expect=8e-51]} {RNA1310_19330.1} {RNA815_18723} |
61. | MligTC455_16525 | 20 | 0.41 | Mlig455_051737 | Neo: - Age: - |
0.972 | - | - | - | - | - | 0.972 | Mlig455_051737 {REF} {Length: 196} {NoTransDecoderORF} {RNA1310_48719} {RNA815_25764} | |
62. | MligTC455_22686 | 26 | 0.55 | Mlig455_000566, Mlig455_030366 | Neo: - Age: - |
GRIK3 | 0.972 | - | - | - | - | - | 0.972 | Mlig455_000566 {REF} {Length: 2943} {Pfam: Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=78.1]; Ligand-gated ion channel [PF00060.28, score=52.0]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=48.7]} {Human: ENSG00000163873, GRIK3, glutamate ionotropic receptor kainate type subunit 3, [Score=157, Expect=5e-39]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=154, Expect=6e-38]; ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=154, Expect=7e-38]} {Mouse: ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=152, Expect=2e-37]; ENSMUSG00000001985, Grik3, glutamate receptor, ionotropic, kainate 3, [Score=151, Expect=4e-37]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=150, Expect=4e-37]; ENSMUSG00000003378, Grik5, glutamate receptor, ionotropic, kainate 5 (gamma 2), [Score=145, Expect=2e-35]} {Dmel: FBgn0039916, Ekar, Eye-enriched kainate receptor, [Score=147, Expect=4e-36]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=137, Expect=4e-33]} {Smed: dd_Smed_v6_22973_0_1, dd_Smed_v6_22973_0_1, [Score=155, Expect=5e-39]} {RNA1310_20394.1} {RNA815_45848} Mlig455_030366 {REF} {Length: 2933} {Pfam: Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=78.1]; Ligand-gated ion channel [PF00060.28, score=51.5]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=48.7]} {Human: ENSG00000163873, GRIK3, glutamate ionotropic receptor kainate type subunit 3, [Score=157, Expect=4e-39]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=154, Expect=5e-38]; ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=152, Expect=2e-37]} {Mouse: ENSMUSG00000001985, Grik3, glutamate receptor, ionotropic, kainate 3, [Score=151, Expect=4e-37]; ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=150, Expect=5e-37]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=150, Expect=4e-37]; ENSMUSG00000003378, Grik5, glutamate receptor, ionotropic, kainate 5 (gamma 2), [Score=145, Expect=3e-35]; ENSMUSG00000032017, Grik4, glutamate receptor, ionotropic, kainate 4, [Score=144, Expect=9e-35]} {Dmel: FBgn0039916, Ekar, Eye-enriched kainate receptor, [Score=147, Expect=5e-36]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=137, Expect=5e-33]} {Smed: dd_Smed_v6_22973_0_1, dd_Smed_v6_22973_0_1, [Score=154, Expect=1e-38]} {RNA1310_20394.1} {RNA815_45848} |
63. | MligTC455_35895 | 102 | 2.12 | Mlig455_063971 | Neo: - Age: - |
RYK | 0.972 | - | - | - | - | - | 0.972 | Mlig455_063971 {REF} {Length: 3496} {Pfam: Protein tyrosine and serine/threonine kinase [PF07714.19, score=209.4]; WIF domain [PF02019.20, score=109.7]; Protein kinase domain [PF00069.27, score=79.1]} {Human: ENSG00000163785, RYK, receptor-like tyrosine kinase, [Score=202, Expect=1e-55]} {Mouse: ENSMUSG00000032547, Ryk, receptor-like tyrosine kinase, [RH, Score=202, Expect=2e-55]} {Dmel: FBgn0015380, drl, derailed, [RH, Score=239, Expect=4e-69]} {Celegans: WBGene00003007, lin-18, Inactive tyrosine-protein kinase RYK, [Score=179, Expect=6e-48]} {Smed: dd_Smed_v6_12594_0_2, dd_Smed_v6_12594_0_2, [Score=201, Expect=3e-55]} {RNA1509_58811} {RNA1310_6671.2} {RNA815_41921} |
64. | MligTC455_36981 | 59 | 1.23 | Mlig455_050314 | Neo: - Age: - Region-enriched R2: 4.760/0.03524 |
ASIC5 | 0.972 | - | - | - | - | - | 0.972 | Mlig455_050314 {REF} {Length: 3328} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=158.3]; Kringle domain [PF00051.20, score=20.5]} {Human: ENSG00000256394, ASIC5, acid sensing ion channel subunit family member 5, [Score=59.3, Expect=2e-08]} {Mouse: ENSMUSG00000028008, Asic5, acid-sensing (proton-gated) ion channel family member 5, [Score=51.6, Expect=3e-06]} {Smed: dd_Smed_v6_16557_0_1, dd_Smed_v6_16557_0_1, [Score=52.8, Expect=6e-07]} {RNA1310_9846.1} {RNA815_21595} |
65. | MligTC455_40961 | 1390 | 28.96 | Mlig455_055735 | Neo: - Age: Down-Up-Up Region-specific R2: 4.023 Region-enriched R2: 3.902/0.00000 |
0.972 | - | - | - | - | - | 0.972 | Mlig455_055735 {REF} {Length: 782} {Pfam: Pancreatic hormone peptide [PF00159.20, score=36.6]} {RNA1509_12482, RNA1509_45015, RNA1509_52082} {RNA1310_48462, RNA1509_12482, RNA1509_45015, RNA1509_52082} {RNA1509_12482, RNA1509_45015, RNA1509_52082, RNA815_25160} | |
66. | MligTC455_41285 | 139 | 2.89 | Mlig455_069278 | Neo: - Age: logFC(26M/2M)=-0.469 Region-enriched R8: 4.794/0.00005 |
TRPM7 | 0.972 | - | - | - | - | - | 0.972 | Mlig455_069278 {REF} {Length: 4453} {tRNA: Val(CAC),pseudo, score=20.3} {Pfam: SLOG in TRPM [PF18139.3, score=112.9]; Ion transport protein [PF00520.33, score=47.3]; SLOG in TRPM, prokaryote [PF18171.3, score=33.2]} {Human: ENSG00000092439, TRPM7, transient receptor potential cation channel subfamily M member 7, [Score=280, Expect=3e-76]} {Mouse: ENSMUSG00000027365, Trpm7, transient receptor potential cation channel, subfamily M, member 7, [Score=281, Expect=9e-77]} {Dmel: FBgn0265194, Trpm, Transient receptor potential cation channel, subfamily M, [Score=292, Expect=1e-81]} {Celegans: WBGene00001796, gtl-2, Gon-Two Like (TRP subfamily), [Score=165, Expect=7e-41]} {Smed: dd_Smed_v6_9288_0_1, dd_Smed_v6_9288_0_1, [Score=411, Expect=1e-123]} {RNA1509_14642} {RNA1310_2379, RNA1509_14642} {RNA1509_14642, RNA815_1069} |
67. | MligTC455_45021 | 381 | 7.95 | Mlig455_046686 | Neo: - Age: Down-Up-Up Region-enriched R2: 3.428/0.03156 |
AVP | 0.972 | - | - | - | - | - | 0.972 | Mlig455_046686 {REF} {Length: 1388} {Pfam: Neurohypophysial hormones, C-terminal Domain [PF00184.19, score=36.2]} {Human: ENSG00000101200, AVP, arginine vasopressin, [Score=54.3, Expect=2e-09]} {Mouse: ENSMUSG00000037727, Avp, arginine vasopressin, [Score=53.1, Expect=3e-09]} {RNA1509_50574} {RNA1310_38922} {RNA815_23813} |
68. | MligTC455_52746 | 33 | 0.7 | Mlig455_036774 | Neo: - Age: - |
0.972 | - | - | - | - | - | 0.972 | Mlig455_036774 {REF} {Length: 1992} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=90.0]} {Smed: dd_Smed_v6_16274_0_1, dd_Smed_v6_16274_0_1, [Score=77.4, Expect=7e-15]} {RNA1310_26715} {RNA815_32348} | |
69. | MligTC455_13905 | 34 | 0.71 | Mlig455_023395 | Neo: - Age: - |
0.971 | - | - | - | - | - | 0.971 | Mlig455_023395 {REF} {Length: 1110} {Smed: dd_Smed_v6_12856_0_1, dd_Smed_v6_12856_0_1, [Score=47.0, Expect=2e-06]} {RNA1509_18233} {RNA1310_51675} {RNA815_25040} | |
70. | MligTC455_22688 | 18 | 0.37 | Mlig455_030413 | Neo: - Age: - |
GRIK3 | 0.971 | - | - | - | - | - | 0.971 | Mlig455_030413 {REF} {Length: 3851} {Pfam: Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=76.0]; Ligand-gated ion channel [PF00060.28, score=51.9]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=45.7]} {Human: ENSG00000163873, GRIK3, glutamate ionotropic receptor kainate type subunit 3, [Score=158, Expect=1e-40]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=153, Expect=7e-39]} {Mouse: ENSMUSG00000001985, Grik3, glutamate receptor, ionotropic, kainate 3, [Score=149, Expect=7e-38]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=149, Expect=6e-38]; ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=148, Expect=2e-37]} {Dmel: FBgn0039916, Ekar, Eye-enriched kainate receptor, [Score=142, Expect=1e-35]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=132, Expect=1e-32]} {Smed: dd_Smed_v6_4267_0_3, dd_Smed_v6_4267_0_3, [Score=149, Expect=5e-38]} {RNA1310_20394.1} {RNA815_45848} |
71. | MligTC455_24614 | 62 | 1.29 | Mlig455_015091, Mlig455_015206 | Neo: - Age: logFC(26M/2M)=-0.441 Region-enriched R4: 7.131/0.00032 Regeneration-downregulated R4: -4.923 Regeneration-depleted R4: -4.923 |
ECT2 | 0.971 | - | - | - | - | - | 0.971 | Mlig455_015091 {REF} {Length: 3092} {Pfam: RhoGEF domain [PF00621.22, score=124.1]; Domain of unknown function (DUF4795) [PF16043.7, score=21.0]; Winged helix-turn helix [PF13592.8, score=19.5]} {Human: ENSG00000114346, ECT2, epithelial cell transforming 2, [Score=78.6, Expect=2e-14]} {Mouse: ENSMUSG00000020640, Itsn2, intersectin 2, [Score=78.6, Expect=2e-14]; ENSMUSG00000027699, Ect2, ect2 oncogene, [Score=74.7, Expect=2e-13]} {Dmel: FBgn0003041, pbl, pebble, [Score=57.0, Expect=6e-08]} {Celegans: WBGene00002297, ect-2, ECT2 (Mammalian Rho GEF) homolog, [Score=67.0, Expect=3e-11]} {Smed: dd_Smed_v6_2922_0_1, dd_Smed_v6_2922_0_1, [Score=59.7, Expect=5e-09]} {RNA1509_21158} {RNA1310_6370} {RNA815_1845} Mlig455_015206 {REF} {Length: 3091} {Pfam: RhoGEF domain [PF00621.22, score=124.1]; Domain of unknown function (DUF4795) [PF16043.7, score=21.0]; Winged helix-turn helix [PF13592.8, score=19.5]} {Human: ENSG00000114346, ECT2, epithelial cell transforming 2, [Score=78.6, Expect=2e-14]} {Mouse: ENSMUSG00000020640, Itsn2, intersectin 2, [Score=78.6, Expect=2e-14]; ENSMUSG00000027699, Ect2, ect2 oncogene, [Score=74.7, Expect=2e-13]} {Dmel: FBgn0003041, pbl, pebble, [Score=57.0, Expect=6e-08]} {Celegans: WBGene00002297, ect-2, ECT2 (Mammalian Rho GEF) homolog, [Score=67.0, Expect=3e-11]} {Smed: dd_Smed_v6_2922_0_1, dd_Smed_v6_2922_0_1, [Score=59.7, Expect=5e-09]} {RNA1509_21158, RNA1509_7033} {RNA1310_6370, RNA1509_21158, RNA1509_7033} {RNA1509_21158, RNA1509_7033, RNA815_1845} |
72. | MligTC455_26601 | 40 | 0.84 | Mlig455_000748 | Neo: - |
0.971 | - | - | - | - | - | 0.971 | Mlig455_000748 {REF} {Length: 4122} {Smed: dd_Smed_v6_17076_0_2, dd_Smed_v6_17076_0_2, [Score=84.3, Expect=1e-17]} {RNA1310_16747.1} {RNA815_12493} | |
73. | MligTC455_30779 | 140 | 2.92 | Mlig455_061630 | Neo: - Age: - |
LRIG2 | 0.971 | - | - | 0.971 | - | - | - | Mlig455_061630 {REF} {Length: 6435} {Pfam: Leucine rich repeat [PF13855.8, score=97.2]; Leucine Rich repeats (2 copies) [PF12799.9, score=39.2]; BspA type Leucine rich repeat region (6 copies) [PF13306.8, score=37.9]} {Human: ENSG00000198799, LRIG2, leucine rich repeats and immunoglobulin like domains 2, [Score=57.4, Expect=2e-07]; ENSG00000255690, TRIL, TLR4 interactor with leucine rich repeats, [Score=55.1, Expect=9e-07]} {Mouse: ENSMUSG00000043496, Tril, TLR4 interactor with leucine-rich repeats, [Score=59.7, Expect=3e-08]} {Dmel: FBgn0004364, 18w, 18 wheeler, [Score=77.0, Expect=1e-13]} {Celegans: WBGene00006593, tol-1, TOLl (Drosophila) family, [Score=75.9, Expect=2e-13]} {RNA1509_37294} {RNA1310_1523.2} {RNA815_1519} |
74. | MligTC455_31696 | 99 | 2.06 | Mlig455_054925 | Neo: - Age: Down-Down-Up |
0.971 | - | - | - | - | - | 0.971 | Mlig455_054925 {REF} {Length: 1987} {RNA1310_24838} {RNA815_18727} | |
75. | MligTC455_33636 | 175 | 3.64 | Mlig455_027209, Mlig455_050659 | Neo: - Age: logFC(26M/2M)=-0.416 Region-enriched R2: 3.904/0.00709 |
CHRNA10 | 0.971 | - | - | - | - | - | 0.971 | Mlig455_027209 {REF} {Length: 1614} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=99.8]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=74.0]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=152, Expect=1e-40]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=150, Expect=8e-40]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=149, Expect=2e-39]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=149, Expect=2e-39]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=148, Expect=6e-39]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=150, Expect=3e-40]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=150, Expect=5e-40]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=144, Expect=5e-38]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=133, Expect=1e-33]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=142, Expect=3e-37]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=142, Expect=3e-37]} {RNA1310_19147.1} {RNA815_8553.1} Mlig455_050659 {REF} {Length: 1670} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=93.6]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=69.9]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=148, Expect=2e-39]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=144, Expect=1e-37]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=141, Expect=1e-36]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=148, Expect=1e-39]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=141, Expect=9e-37]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=134, Expect=4e-34]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=144, Expect=7e-38]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=141, Expect=6e-37]} {RNA1310_19147.1} {RNA815_8553.1} |
76. | MligTC455_38126 | 181 | 3.78 | Mlig455_001217 | Neo: - Age: Down-Up-Down |
MOK | 0.971 | - | - | - | - | - | 0.971 | Mlig455_001217 {REF} {Length: 3206} {TRANSSPLICED} {Pfam: Protein kinase domain [PF00069.27, score=225.3]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=101.8]; Lipopolysaccharide kinase (Kdo/WaaP) family [PF06293.16, score=23.8]; RIO1 family [PF01163.24, score=20.1]; Kinase-like [PF14531.8, score=19.8]; Kinetochore Sim4 complex subunit FTA2 [PF13095.8, score=18.7]} {Human: ENSG00000080823, MOK, MOK protein kinase, [RH, Score=394, Expect=4e-133]} {Mouse: ENSMUSG00000056458, Mok, MOK protein kinase, [RH, Score=397, Expect=1e-134]} {Dmel: FBgn0259712, CG42366, [Score=259, Expect=5e-78]} {Celegans: WBGene00001121, dyf-5, Serine/threonine-protein kinase dyf-5, [Score=230, Expect=2e-69]} {Smed: dd_Smed_v6_15542_0_1, dd_Smed_v6_15542_0_1, [RH, Score=416, Expect=2e-141]} {RNA1509_23114, RNA1509_48468} {RNA1310_15433.1, RNA1509_23114, RNA1509_48468} {RNA1509_23114, RNA1509_48468, RNA815_13706} |
77. | MligTC455_40328 | 26 | 0.54 | Mlig455_054438 | Neo: - Age: - |
0.971 | - | - | - | - | - | 0.971 | Mlig455_054438 {REF} {Length: 1987} {NoTransDecoderORF} {RNA1509_27938} {RNA1310_55383} | |
78. | MligTC455_40766 | 99 | 2.05 | Mlig455_012729 | Neo: - Age: Down-Down-Up |
TP53I11 | 0.971 | - | - | 0.971 | - | - | - | Mlig455_012729 {REF} {Length: 2823} {Pfam: Tumour protein p53-inducible protein 11 [PF14936.8, score=89.2]} {Human: ENSG00000175274, TP53I11, tumor protein p53 inducible protein 11, [Score=65.5, Expect=4e-13]} {Mouse: ENSMUSG00000068735, Trp53i11, transformation related protein 53 inducible protein 11, [Score=66.6, Expect=2e-13]} {Celegans: WBGene00021185, Y9C12A.1, [Score=67.0, Expect=2e-13]} {RNA1310_38478} {RNA815_33223} |
79. | MligTC455_01197 | 6 | 0.12 | Mlig455_047852 | Neo: - Age: - |
0.97 | - | - | - | - | - | 0.970 | Mlig455_047852 {REF} {Length: 829} {RNA1509_18414} {RNA1310_42507} {RNA815_19425} | |
80. | MligTC455_14856 | 14 | 0.29 | Mlig455_023184 | Neo: - Age: - |
ANGPTL7 | 0.97 | - | - | - | - | - | 0.970 | Mlig455_023184 {REF} {Length: 1290} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=129.4]; PAN domain [PF00024.28, score=23.8]} {Human: ENSG00000171819, ANGPTL7, angiopoietin like 7, [Score=105, Expect=1e-25]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=103, Expect=3e-24]} {Mouse: ENSMUSG00000028989, Angptl7, angiopoietin-like 7, [Score=104, Expect=1e-25]; ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=102, Expect=4e-24]} {Dmel: FBgn0033312, CG8642, [Score=96.7, Expect=2e-22]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=98.6, Expect=5e-23]} {RNA1509_58115} {RNA1310_36699.1} {RNA815_17918.1} |
81. | MligTC455_15253 | 11 | 0.22 | Mlig455_010266 | Neo: - Age: - |
0.97 | - | - | - | - | - | 0.970 | Mlig455_010266 {REF} {Length: 252} {NoTransDecoderORF} {RNA815_48483} | |
82. | MligTC455_19276 | 1694 | 35.28 | Mlig455_057303 | Neo: - Age: Down-Down-Up Region-specific R2: 5.711 Region-enriched R2: 6.117/0.00000 |
0.97 | - | - | - | - | - | 0.970 | Mlig455_057303 {REF} {Length: 1196} {Pfam: TATA-binding related factor (TRF) of subunit 20 of Mediator complex [PF08612.13, score=80.6]} {Smed: dd_Smed_v6_9879_0_1, dd_Smed_v6_9879_0_1, [RH, Score=73.9, Expect=1e-15]} {RNA1509_58478} {RNA1310_35292} {RNA815_20171} | |
83. | MligTC455_19278 | 4335 | 90.31 | Mlig455_057304, Mlig455_070944 | Neo: - Age: logFC(26M/2M)=0.686 Region-specific R2: 5.590 Region-enriched R2: 5.465/0.00000 |
CHRNA10 | 0.97 | - | - | - | - | - | 0.970 | Mlig455_057304 {REF} {Length: 1001} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=71.6]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=77.0, Expect=2e-16]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=75.9, Expect=4e-16]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=75.5, Expect=6e-16]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=73.9, Expect=2e-15]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=93.6, Expect=2e-22]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=100, Expect=5e-25]} {Smed: dd_Smed_v6_11955_0_1, dd_Smed_v6_11955_0_1, [Score=82.8, Expect=8e-19]} {RNA1509_23115} {RNA1310_34970} {RNA815_15305.1} Mlig455_070944 {REF} {Length: 1060} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=88.2]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=95.9, Expect=6e-22]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=96.3, Expect=3e-22]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=94.7, Expect=1e-21]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=112, Expect=7e-28]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=118, Expect=4e-30]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=98.6, Expect=2e-23]} {RNA1509_23115, RNA1509_43907, RNA1509_9432} {RNA1310_34970, RNA1509_23115, RNA1509_43907, RNA1509_9432} {RNA1509_23115, RNA1509_43907, RNA1509_9432, RNA815_15305.1} |
84. | MligTC455_47420 | 218 | 4.54 | Mlig455_017159, Mlig455_048110 | Neo: - Age: - Region-specific R2: 6.469 Region-enriched R2: 5.851/0.00135 |
0.97 | - | - | - | - | - | 0.970 | Mlig455_017159 {REF} {Length: 1062} {RNA1509_35349} {RNA1310_81586} Mlig455_048110 {REF} {Length: 527} {RNA1310_81586} |
|
85. | MligTC455_50146 | 37 | 0.77 | Mlig455_050983 | Neo: - Age: - |
NPSR1 | 0.97 | - | - | - | - | - | 0.970 | Mlig455_050983 {REF} {Length: 1326} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=105.5]} {Human: ENSG00000187258, NPSR1, neuropeptide S receptor 1, [Score=63.5, Expect=1e-10]} {Mouse: ENSMUSG00000029255, Gnrhr, gonadotropin releasing hormone receptor, [Score=66.6, Expect=4e-12]; ENSMUSG00000044014, Npy5r, neuropeptide Y receptor Y5, [Score=65.5, Expect=3e-11]} {Dmel: FBgn0036278, CrzR, Corazonin receptor, [Score=72.8, Expect=1e-13]} {Celegans: WBGene00013642, daf-38, G-protein coupled receptor daf-38, [Score=65.5, Expect=1e-11]} {Smed: dd_Smed_v6_75337_0_1, dd_Smed_v6_75337_0_1, [Score=66.6, Expect=2e-12]} {RNA1310_64751.2} |
86. | MligTC455_50454 | 394 | 8.21 | Mlig455_057487 | Neo: - Age: Down-Up-Up Region-enriched R2: 5.517/0.00000 |
0.97 | - | - | - | - | - | 0.970 | Mlig455_057487 {REF} {Length: 724} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=33.5]; Nematode insulin-related peptide beta type [PF03488.16, score=20.4]} {RNA1509_58074} {RNA1310_51990} {RNA815_25071} | |
87. | MligTC455_02985 | 22 | 0.45 | Mlig455_057981 | Neo: - Age: - |
0.969 | - | - | - | - | - | 0.969 | Mlig455_057981 {REF} {Length: 299} {RNA1509_13251} {RNA1310_4626} | |
88. | MligTC455_14310 | 27 | 0.56 | Mlig455_021495 | Neo: - Age: - Regeneration-upregulated R2: 3.309 Regeneration-enriched R2: 3.309 |
0.969 | - | - | - | - | - | 0.969 | Mlig455_021495 {REF} {Length: 4005} {RNA1509_54101} {RNA1310_16857} {RNA815_29628} | |
89. | MligTC455_25072 | 4443 | 92.56 | Mlig455_015899 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-1.175 Region-enriched R2: 4.389/0.00000 |
PI16 | 0.969 | - | - | - | - | - | 0.969 | Mlig455_015899 {REF} {Length: 2017} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=71.8]} {Human: ENSG00000164530, PI16, peptidase inhibitor 16, [Score=112, Expect=1e-26]} {Mouse: ENSMUSG00000024011, Pi16, peptidase inhibitor 16, [RH, Score=115, Expect=5e-28]} {Dmel: FBgn0038126, CG8483, [Score=95.5, Expect=2e-21]} {Celegans: WBGene00011462, vap-2, Venom-Allergen-like Protein, [RH, Score=85.5, Expect=5e-18]} {Smed: dd_Smed_v6_2512_0_1, dd_Smed_v6_2512_0_1, [Score=140, Expect=2e-39]} {RNA1509_5027} {RNA1310_1356.1} {RNA815_4508} |
90. | MligTC455_30160 | 55 | 1.15 | Mlig455_035128 | Neo: - Age: - Region-enriched R2: 5.270/0.01686 |
TCF7L1 | 0.969 | - | - | - | - | - | 0.969 | Mlig455_035128 {REF} {Length: 2946} {Pfam: HMG (high mobility group) box [PF00505.21, score=79.2]; HMG-box domain [PF09011.12, score=34.5]} {Human: ENSG00000152284, TCF7L1, transcription factor 7 like 1, [RH, Score=161, Expect=1e-42]; ENSG00000138795, LEF1, lymphoid enhancer binding factor 1, [RH, Score=158, Expect=7e-43]; ENSG00000081059, TCF7, transcription factor 7, [RH, Score=156, Expect=2e-41]} {Mouse: ENSMUSG00000055799, Tcf7l1, transcription factor 7 like 1 (T cell specific, HMG box), [RH, Score=161, Expect=8e-43]; ENSMUSG00000027985, Lef1, lymphoid enhancer binding factor 1, [RH, Score=158, Expect=9e-44]; ENSMUSG00000000782, Tcf7, transcription factor 7, T cell specific, [RH, Score=155, Expect=1e-42]} {Dmel: FBgn0085432, pan, pangolin, [RH, Score=156, Expect=1e-40]} {Celegans: WBGene00004077, pop-1, [Score=108, Expect=2e-25]} {Smed: dd_Smed_v6_34144_0_1, dd_Smed_v6_34144_0_1, [RH, Score=166, Expect=6e-48]} {RNA1509_46571} {RNA1310_11181} {RNA815_36690} |
91. | MligTC455_31626 | 38 | 0.79 | Mlig455_032857 | Neo: - Age: - |
SLC23A1 | 0.969 | - | - | - | - | - | 0.969 | Mlig455_032857 {REF} {Length: 2462} {Pfam: Permease family [PF00860.22, score=281.6]} {Human: ENSG00000170482, SLC23A1, solute carrier family 23 member 1, [Score=400, Expect=4e-132]; ENSG00000089057, SLC23A2, solute carrier family 23 member 2, [Score=380, Expect=1e-123]} {Mouse: ENSMUSG00000029847, Slc23a4, solute carrier family 23 member 4, [Score=421, Expect=4e-140]} {Dmel: FBgn0037807, CG6293, [Score=355, Expect=2e-115]} {Celegans: WBGene00008252, C51E3.6, [RH, Score=250, Expect=1e-75]} {Smed: dd_Smed_v6_9401_0_1, dd_Smed_v6_9401_0_1, [RH, Score=304, Expect=9e-96]} {RNA1509_16219} {RNA1310_39982} {RNA815_42063} |
92. | MligTC455_43412 | 88 | 1.82 | Mlig455_057184 | Neo: - Age: - |
ANKRD60 | 0.969 | - | - | - | - | - | 0.969 | Mlig455_057184 {REF} {Length: 1347} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=42.6]; Ankyrin repeat [PF13606.8, score=33.4]; Ankyrin repeats (many copies) [PF13857.8, score=33.2]; Ankyrin repeat [PF00023.32, score=32.8]; Ankyrin repeats (many copies) [PF13637.8, score=23.4]} {Human: ENSG00000124227, ANKRD60, ankyrin repeat domain 60, [Score=79.3, Expect=5e-16]} {Mouse: ENSMUSG00000027517, Ankrd60, ankyrin repeat domain 60, [Score=70.1, Expect=4e-13]} {Dmel: FBgn0011747, Ank, Ankyrin, [Score=50.8, Expect=1e-06]} {Celegans: WBGene00003196, mel-11, MEL-11, [Score=51.6, Expect=6e-07]} {Smed: dd_Smed_v6_8330_0_1, dd_Smed_v6_8330_0_1, [Score=129, Expect=1e-33]} {RNA1310_18551} {RNA815_10264.1} |
93. | MligTC455_45666 | 652 | 13.58 | Mlig455_013011, Mlig455_013040 | Neo: - Age: Up-Down-Up Region-specific R2: 4.509 Region-enriched R2: 3.140/0.01108 |
0.969 | - | - | - | - | - | 0.969 | Mlig455_013011 {REF} {Length: 1193} {RNA1509_13068} {RNA1310_46610} {RNA815_23273} Mlig455_013040 {REF} {Length: 923} {RNA1509_13068} {RNA1310_46610, RNA1509_13068} {RNA1509_13068, RNA815_23273} |
|
94. | MligTC455_47923 | 9994 | 208.21 | Mlig455_031159, Mlig455_031167 | Neo: - Age: logFC(26M/2M)=-0.423 |
CCDC63 | 0.969 | - | - | - | - | - | 0.969 | Mlig455_031159 {REF} {Length: 2325} {TRANSSPLICED} {Pfam: Initiation control protein YabA [PF06156.15, score=22.9]} {Human: ENSG00000173093, CCDC63, coiled-coil domain containing 63, [Score=181, Expect=9e-50]} {Mouse: ENSMUSG00000043036, Ccdc63, coiled-coil domain containing 63, [Score=163, Expect=3e-43]; ENSMUSG00000040189, Ccdc114, coiled-coil domain containing 114, [Score=158, Expect=3e-41]} {Dmel: FBgn0038452, CG14905, [Score=159, Expect=9e-43]} {Celegans: WBGene00001328, epi-1, Laminin-like protein epi-1, [Score=48.5, Expect=1e-05]} {Smed: dd_Smed_v6_4191_0_1, dd_Smed_v6_4191_0_1, [Score=431, Expect=8e-146]} {RNA1509_2578, RNA1509_9264} {RNA1310_10129.1, RNA1509_2578, RNA1509_9264} {RNA1509_2578, RNA1509_9264, RNA815_3341.1} Mlig455_031167 {REF} {Length: 2293} {TRANSSPLICED} {Pfam: Initiation control protein YabA [PF06156.15, score=22.9]} {Human: ENSG00000173093, CCDC63, coiled-coil domain containing 63, [Score=181, Expect=9e-50]} {Mouse: ENSMUSG00000043036, Ccdc63, coiled-coil domain containing 63, [Score=163, Expect=3e-43]; ENSMUSG00000040189, Ccdc114, coiled-coil domain containing 114, [Score=158, Expect=3e-41]} {Dmel: FBgn0038452, CG14905, [Score=159, Expect=9e-43]} {Celegans: WBGene00001328, epi-1, Laminin-like protein epi-1, [Score=48.5, Expect=1e-05]} {Smed: dd_Smed_v6_4191_0_1, dd_Smed_v6_4191_0_1, [Score=431, Expect=8e-146]} {RNA1509_1172, RNA1509_13163, RNA1509_16375, RNA1509_2578} {RNA1310_10129.1, RNA1509_1172, RNA1509_13163, RNA1509_16375} {RNA1509_1172, RNA1509_13163, RNA1509_16375, RNA815_3341.1} |
95. | MligTC455_29408 | 45 | 0.94 | Mlig455_038322 | Neo: - Age: - Region-enriched R2: 8.586/0.00762 |
MB | 0.968 | - | - | - | - | - | 0.968 | Mlig455_038322 {REF} {Length: 2059} {Pfam: Globin [PF00042.24, score=57.8]} {Human: ENSG00000198125, MB, myoglobin, [RH, Score=47.8, Expect=5e-07]} {Mouse: ENSMUSG00000018893, Mb, myoglobin, [RH, Score=45.4, Expect=2e-06]} {Celegans: WBGene00008996, glb-14, GLoBin related, [Score=51.6, Expect=4e-08]} {Smed: dd_Smed_v6_15997_0_1, dd_Smed_v6_15997_0_1, [RH, Score=63.5, Expect=1e-12]} {RNA1509_48898} {RNA1310_47695} {RNA815_7096.1} |
96. | MligTC455_43095 | 294 | 6.13 | Mlig455_028880 | Neo: - Age: - Region-enriched R2: 5.606/0.00021 |
0.968 | - | - | - | - | - | 0.968 | Mlig455_028880 {REF} {Length: 822} {RNA1509_32622} {RNA1310_67920, RNA1509_32622} {RNA1509_32622, RNA815_31932.2} | |
97. | MligTC455_53413 | 249 | 5.2 | Mlig455_035022 | Neo: - Age: - Region-specific R2: 4.451 Region-enriched R2: 3.023/0.00460 |
RP1 | 0.968 | - | - | - | - | - | 0.968 | Mlig455_035022 {REF} {Length: 5065} {Pfam: PLAT/LH2 domain [PF01477.25, score=155.8]; Doublecortin [PF03607.19, score=103.5]; Embryo-specific protein 3, (ATS3) [PF06232.13, score=22.0]} {Human: ENSG00000104237, RP1, RP1, axonemal microtubule associated, [Score=473, Expect=5e-146]} {Mouse: ENSMUSG00000025900, Rp1, retinitis pigmentosa 1 (human), [Score=454, Expect=1e-136]} {Dmel: FBgn0261387, CG17528, [Score=56.6, Expect=1e-07]} {Celegans: WBGene00006993, zyg-8, Serine/threonine-protein kinase zyg-8, [Score=75.5, Expect=2e-13]} {Smed: dd_Smed_v6_10315_0_2, dd_Smed_v6_10315_0_2, [Score=698, Expect=0.0]} {RNA1509_57003} {RNA1310_2710} {RNA815_13802.1} |
98. | MligTC455_53467 | 98 | 2.05 | Mlig455_032611 | Neo: - Age: Down-Down-Up Region-enriched R8: 4.858/0.00151 |
0.968 | - | - | - | - | - | 0.968 | Mlig455_032611 {REF} {Length: 2547} {Pfam: Carbohydrate binding domain (family 19) [PF03427.15, score=19.0]} {RNA1509_1990} {RNA1310_48790} {RNA815_9320.1} | |
99. | MligTC455_16148 | 198 | 4.12 | Mlig455_057689 | Neo: - Age: - |
KLHDC8A | 0.967 | - | - | - | - | - | 0.967 | Mlig455_057689 {REF} {Length: 1806} {Pfam: Kelch motif [PF13964.8, score=56.9]; Kelch motif [PF01344.27, score=52.7]; Kelch motif [PF07646.17, score=37.5]; Galactose oxidase, central domain [PF13418.8, score=35.1]; Kelch motif [PF13854.8, score=27.6]} {Human: ENSG00000162873, KLHDC8A, kelch domain containing 8A, [Score=58.5, Expect=2e-09]} {Mouse: ENSMUSG00000042115, Klhdc8a, kelch domain containing 8A, [Score=63.9, Expect=1e-10]} {Smed: dd_Smed_v6_14507_0_1, dd_Smed_v6_14507_0_1, [RH, Score=209, Expect=4e-63]} {RNA1509_58319} {RNA1310_20213} {RNA815_8052} |
100. | MligTC455_27673 | 123 | 2.56 | Mlig455_041241, Mlig455_053095 | Neo: - Age: Up-Down-Up |
GLRA1, GLRA3 | 0.967 | - | - | 0.967 | - | - | - | Mlig455_041241 {REF} {Length: 4857} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=165.7]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=84.7]} {Human: ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=253, Expect=3e-78]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [Score=249, Expect=9e-77]; ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=246, Expect=1e-75]} {Mouse: ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=246, Expect=7e-76]; ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=244, Expect=2e-74]; ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [Score=243, Expect=1e-74]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [Score=240, Expect=2e-73]} {Dmel: FBgn0024963, GluClalpha, [Score=256, Expect=1e-79]} {Celegans: WBGene00000233, avr-15, GluClalpha2B protein, [RH, Score=247, Expect=6e-76]} {Smed: dd_Smed_v6_11342_0_1, dd_Smed_v6_11342_0_1, [RH, Score=440, Expect=1e-151]} {RNA1509_35986} {RNA1310_28655} {RNA815_20247} Mlig455_053095 {REF} {Length: 4892} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=163.1]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=83.4]} {Human: ENSG00000145888, GLRA1, glycine receptor alpha 1, [Score=254, Expect=9e-79]; ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=251, Expect=1e-77]; ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=243, Expect=9e-75]} {Mouse: ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [Score=248, Expect=9e-77]; ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=244, Expect=5e-75]; ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=242, Expect=4e-74]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [Score=236, Expect=2e-72]} {Dmel: FBgn0024963, GluClalpha, [Score=257, Expect=4e-80]} {Celegans: WBGene00000233, avr-15, GluClalpha2B protein, [Score=252, Expect=3e-78]} {Smed: dd_Smed_v6_11342_0_1, dd_Smed_v6_11342_0_1, [Score=449, Expect=1e-155]} {RNA1509_54479} {RNA1310_56579} {RNA815_20247} |